It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 | Hyderabad, Telangana, India | Dissolved Under Section 59(8)Insannova Clinicals Private Limited, a dissolved under section 59(8) private limited company, was established on 30 July 2012 in Hyderabad, Telangana, India. Engaging in science research within the research & development sector, it holds CIN: U73100TG2012PTC082233. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.10 M and a paid-up capital of ₹3.02 M.
It upholds a compliant status. Its leadership includes Madhavi Gaddampally Reddy (Director), Aashritha Marepalli (Director), Satyanarayana Samatam (Director). Past directors included Hanumantha Rao Marepalli, Aashritha Marepalli. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Ghmc No. 24-239, Mig 239, Kphb Main Road Beside Remedy Hospital, Kukatpally, Hyderabad, Telangana, 500072.
U73100TG2012PTC082233
082233
30 July 2012
₹3.10 M
₹3.02 M
Roc Hyderabad
Unlisted
Dissolved Under Section 59(8)
Explore comprehensive insights into Insannova Clinicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhavi Gaddampally Reddy | Director | 30 Jul 2012 | Current |
| Aashritha Marepalli | Director | 10 Aug 2020 | Current |
| Satyanarayana Samatam | Director | 21 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Apr 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Insannova Clinicals Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 3.03% decrease. The company also saw a slight improvement in profitability, with a 6.41% increase in profit. The company's net worth Soared by an impressive increase of 16.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Insannova Clinicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Insannova Clinicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Insannova Clinicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Insannova Clinicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Insannova Clinicals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
The activity Insannova Clinicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was completed.
Aashritha Marepalli was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Satyanarayana Samatam was appointed as a Director was appointed as a Director on 21 Aug 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.
Madhavi Gaddampally Reddy was appointed as a Director was appointed as a Director on 30 Jul 2012 & has been associated with this company since 13 years 5 months . was recorded as a recent event.
Insannova Clinicals Private Limited was registered on 30 Jul 2012 with Roc Hyderabad & aged 13 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Insannova Clinicals Private Limited is U73100TG2012PTC082233.
Insannova Clinicals Private Limited is headquartered at Ghmc No. 24-239, Mig 239, Kphb Main Road Beside Remedy Hospital, Kukatpally, Hyderabad, Telangana, 500072.
Insannova Clinicals Private Limited was incorporated on 30 July 2012.
The current directors of Insannova Clinicals Private Limited are
The primary industry of Insannova Clinicals Private Limited is Research & Development.
Insannova Clinicals Private Limited is unlisted.
The authorized capital of Insannova Clinicals Private Limited is ₹3.10 M, and the paid-up capital is ₹3.02 M.
The compliance status of Insannova Clinicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX